Business
Travere Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results
SAN DIEGO, February 12, 2026--Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report fourth quarter and full year 2025 financial results on Thursday, February 19, 2026, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.
About this update from Travere Therapeutics, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1604,"height":352,"url":"https://media.zenfs.com/en/business-wire.com/8653af7422fa996169256ccd6075cffb"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ZSfqZcUHyQ1RZqG0OygOlg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTIxMTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/8653af7422fa996169256ccd6075cffb","width":960,"height":211},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/jduUUJg6GcWhBf3KYAm5EQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD01MjY7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/8653af7422fa996169256ccd6075cffb","width":1200,"height":263}},"lazy":false},{"type":"text","content":"SAN DIEGO, February 12, 2026--(BUSINESS WIRE)--Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report fourth quarter and full year 2025 financial results on Thursday, February 19, 2026, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.","length":390,"tagName":"p"},{"type":"text","content":"The webcast and dial-in information can be accessed on the Investor page of Travere’s website at https://ir.travere.com/events-and-presentations. Following the live webcast, an archived version of the call will be available for 30 days on the Company’s website.","length":261,"tagName":"p"},{"type":"text","content":"About Travere Therapeutics","length":26,"tagName":"p"},{"type":"text","content":"At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.","length":666,"tagName":"p"},{"type":"text","content":"View source version on businesswire.com: https://www.busines...